Chloroquine Prophylaxis for Health Care Workers at Risk for COVID
Chloroquine Prophylaxis (Prevention) for NewYork-Presbyterian Hospital (NYP) Health Care Workers at Risk for COVID-19
Sponsor: Columbia University
Enrolling: Male and Female Patients
Study Length: 3 Months
IRB Number: AAAS9992
U.S. Govt. ID: NCT04349371
Contact: Tommy Chen: 212-342-9051 /
Additional Study Information: The purpose of this research study is to determine if chloroquine is effective in health care workers with moderate to high risk of exposure to COVID-19 in preventing symptomatic COVID-19 infections. The time frame for your involvement in the study is 3 months. During month 0, participants will be screened and randomized (like a flip of a coin) to a 3-month chloroquine versus an identical course of placebo. A placebo is a sugar pill which has no active ingredient. Participants will be followed by the investigator during months 1-3 either through in person visit or through telemedicine.
This study is closed
Anca Askanase, MD, MPH
Do You Qualify?
Are you 18 years of age or older? Yes No
Are you employed by NewYork-Presbyterian Hospital? Yes No
Does your work involve patient contact and possible exposure to COVID-19 at least 2 days/week for at least 8 hours/day? Yes No
Are you already taking chloroquine for any other indications? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Tommy Chen